EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DNMT3A facilitates breast cancer progression via regulating ADAMTS8 mediated EGFR-MEK-ERK activation

Shan Yang, Meng Cheng, Shaonan Zhang, Haoqi Wang, Jiaxing Wang, Xi Zhang, Yunzhe Mi, Sainan Li iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0321889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Shan Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Breast Neoplasms, DNA (Cytosine-5-)-Methyltransferases, MAP Kinase Signaling System, ADAMTS Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The government of Hebei Province supports the outstanding talents project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ADAMTS8 inactivation by epigenetic modifications has been reported in various tumors, and the dysregulation of ADAMTS8 expression is associated with poor clinical outcomes, cancer cell invasion, and metastasis. De novo methylation, involving DNMT3A, plays an important role in cancer development; however, it remains unclear whether DNMT3A regulates the progressive expression of breast cancer by regulating ADAMTS8. Through published cancer-related datasets and clinical validation, we found that ADAMTS8 and DNMT3A expression negatively correlated in breast cancer, and both associated with patient prognosis. Related cell experiments have shown that DNMT3A overexpression promotes breast cancer cell proliferation, migration, invasion, and apoptosis, whereas silencing DNMT3A has the opposite effect. Through Co-IP experiments, we confirmed that DNMT3A binds directly to ADAMTS8. Methylation-specific PCR (MSP) experiments confirmed that DNMT3A mediates ADAMTS8 promoter methylation in breast cancer. In addition, DNMT3A activated the EGFR-MEK-ERK signaling pathway by effectively downregulating ADAMTS8, whereas silencing ADAMTS8 effectively inhibited this signaling pathway. Taken together, our findings suggest that DNMT3A activates the EGFR-MEK-ERK signaling pathway by silencing ADAMTS8 transcription through methylation, thereby promoting breast cancer development. Therefore, DNMT3A may serve as an inhibitory target in breast cancer-targeted therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDNA (Cytosine-5-)-MethyltransferasesMAP Kinase Signaling SystemADAMTS ProteinsHumansFemaleErbB ReceptorsDNA Methyltransferase 3ADNA MethylationGene Expression Regulation, NeoplasticCell ProliferationDisease ProgressionCell Line, TumorCell MovementPromoter Regions, GeneticApoptosis

Substanzen

ErbB ReceptorsDNA Methyltransferase 3ADNA (Cytosine-5-)-MethyltransferasesDNMT3A protein, humanEGFR protein, humanADAMTS8 protein, humanADAMTS Proteins

Autor:innen und Institutionen

  • Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Hebei Key Laboratory of Breast Cancer Molecular Medicine, Shijiazhuang, Hebei, China.

ORCID-Profile: Sainan Li

Förderung

  • The government of Hebei Province supports the outstanding talents project

Zitieren

APA

Yang, S., Cheng, M., Zhang, S., Wang, H., Wang, J., Zhang, X., Mi, Y., & Li, S. (2025). DNMT3A facilitates breast cancer progression via regulating ADAMTS8 mediated EGFR-MEK-ERK activation. PLOS One. https://doi.org/10.1371/journal.pone.0321889

Vancouver

Yang S, Cheng M, Zhang S, Wang H, Wang J, Zhang X, et al. DNMT3A facilitates breast cancer progression via regulating ADAMTS8 mediated EGFR-MEK-ERK activation. PLOS One. 2025. doi:10.1371/journal.pone.0321889

BibTeX
@article{Yang2025,
  author = {Yang, Shan and Cheng, Meng and Zhang, Shaonan and Wang, Haoqi and Wang, Jiaxing and Zhang, Xi and Mi, Yunzhe and Li, Sainan},
  title = {DNMT3A facilitates breast cancer progression via regulating ADAMTS8 mediated EGFR-MEK-ERK activation},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0321889}
}
Kostenlos starten →